# Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

> **NCT06505993** · NA · SUSPENDED · sponsor: **Marc Kiviniemi** · enrollment: 2250 (estimated)

## Conditions studied

- COVID-19
- Vaccine Hesitancy

## Interventions

- **BEHAVIORAL:** Health Communication
- **BEHAVIORAL:** Health Communication + Structural

## Key facts

- **NCT ID:** NCT06505993
- **Lead sponsor:** Marc Kiviniemi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 2250 (ESTIMATED)
- **Why stopped:** Potential study redesign
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06505993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06505993, "Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06505993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*